ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Bishop, Scein, Vaitkevicuis Named To NCAB; Hopkins Breaks Ground for Larger Center

October 7, 1994

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009

Arizona Cancer Center Convinces State To Set Lower Limits For Aflatoxin

February 23, 1979

NCI Bypass Budget Seeks $3.64 Billion

January 20, 1995

NCI Budget Chief John Hartinger Retires.

August 4, 2006

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

October 31, 2008